|
| No. = 32 | |
| Age | Mean ± SD | 44.84 ± 9.09 |
| Range | 26 - 59 | |
| Site | Central | 5 (15.6%) |
| Inferior pole | 4 (12.5%) | |
| LIQ | 5 (15.6%) | |
| LOQ | 3 (9.4%) | |
| UOQ | 10 (31.2%) | |
| Upper pole | 5 (15.6%) | |
| Pathology | IDC | 26 (81.2%) |
| ILC | 6 (18.8%) | |
| Size after | Mean ± SD | 4.06 ± 0.70 |
| Range | 2.8 - 5.5 | |
| Size before | Mean ± SD | 5.23 ± 0.85 |
| Range | 3.5 - 6.8 | |
| ER | Negative | 12 (37.5%) |
| Positive | 20 (62.5%) | |
| PR | Negative | 13 (40.6%) |
| Positive | 19 (59.4%) | |
| HER-2 | Negative | 24 (75.0%) |
| Positive | 8 (25.0%) | |
| Positive ALN | Mean ± SD | 5.07 ± 2.52 |
| Range | 2 - 12 | |
| Total ALNC | Mean ± SD | 20.07 ± 4.24 |
| Range | 12 - 28 | |